Skip to main content

Table 2 Use of diagnostics to patients with and without fever in pre- and post-RDT implementation HDSS areas

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

Characteristic Ifakara HDSS (pre-RDT implementation area) Rufiji HDSS (post-RDT implementation area) P-value (site)
  n/N %(95%CI) n/N %(95%CI)  
All patients tested by either RDT or microscopy 354/761 46.5 (36.3-57.1) 441/710 62.1 (50.3-72.6) 0.05
 RDT 132/761 17.4 (11.0-26.2) 309/710 43.5 (32.4-55.4) < 0.01
 Microscopy 242/761 31.8 (28.5-35.2) 132/710 18.6 (15.8-21.7) 0.05
Correct testing: Patients with fever tested either RDT or microscopy 314/627 50.1 (38.9-61.2) 400/620 64.5 (51.8-75.5) 0.09
 RDT 123/627 19.6 (12.4-29.6) 282/620 45.5 (33.3-58.2) < 0.01
 Microscopy 210/627 33.5 (29.8-37.3) 118/620 19.0 (16.0-22.3) 0.04
Over-testing: Patients without fever tested with either RDT or microscopy 40/134 29.9 (16.5-47.9) 41/90 45.6 (32.9-58.8) 0.15
 High season 5/60 8.3 (3.6-18.0) 26/56 46.4 (33.2-60.2) <0.01
 Low season 35/74 47.3 (24.0-71.9) 15/34 44.1 (22.0-68.9) 0.86